May 1st 2025
The Inflation Reduction Act's (IRAs) drug negotiation provisions will fundamentally reshape Medicare drug pricing, provider reimbursement, and healthcare delivery dynamics across Part B and commercial markets, according to panelists at Asembia’s AXS25 Summit.
Optical Coherence Tomography Could Reduce Age-Related Macular Degeneration Treatment Cost
January 10th 2018Use of optical coherence tomography as a guiding therapy for neovascular age-related macular degeneration resulted in an estimated accrued savings of $9 billion for the US government through Medicare.